Evolent director granted 41,096 restricted stock units
Barbarosh Craig A. reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Barbarosh Craig A. reported acquisition or exercise transactions in this Form 4 filing.
Evolent Health director Craig A. Barbarosh received an equity grant of 41,096 restricted stock units of Class A Common Stock. The award was made at no cash cost to him as part of Evolent Health’s 2015 Omnibus Incentive Compensation Plan. These units are scheduled to vest on the earlier of June 4, 2027, or the company’s 2027 annual meeting, contingent on his continued board service. Following this grant, he directly holds 95,031 shares of Class A Common Stock.
Insider Trade Summary
Grant/Award: 41,096 shares
Grant/Award
1 txn
Insider
Barbarosh Craig A.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 41,096 | $0.00 | $0.00 |
Holdings After Transaction:
Class A Common Stock — 95,031 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock units granted to Mr. Barbarosh pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- F2. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
Key Figures
Restricted stock units granted: 41,096 units
Price per share for grant: $0.0000 per share
Shares held after transaction: 95,031 shares
+1 more
4 metrics
Restricted stock units granted
41,096 units
Equity award to director Craig A. Barbarosh on June 4, 2026
Price per share for grant
$0.0000 per share
Reported transaction price for Class A Common Stock award
Shares held after transaction
95,031 shares
Director’s direct Class A Common Stock ownership following grant
Vesting date trigger
June 4, 2027
Vests on this date or at 2027 annual meeting, whichever is earlier
Key Terms
restricted stock units, Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan, vest, Class A Common Stock
4 terms
restricted stock units financial
"Represents restricted stock units granted to Mr. Barbarosh pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan financial
"Represents restricted stock units granted to Mr. Barbarosh pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
vest financial
"Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Class A Common Stock financial
"security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Evolent Health (EVH) director Craig Barbarosh report on this Form 4?
Craig A. Barbarosh reported receiving 41,096 restricted stock units of Evolent Health Class A Common Stock as an equity award. The grant was made at no cash cost to him and increases his directly held position to 95,031 shares after the transaction.
When do Craig Barbarosh’s new Evolent Health restricted stock units vest?
The restricted stock units vest on the earlier of June 4, 2027, or Evolent Health’s 2027 annual meeting. Vesting is contingent on his continued service as a director through the vesting date, aligning the award with his ongoing board tenure and responsibilities.
What plan governs the equity grant to Evolent Health director Craig Barbarosh?
The grant to Craig A. Barbarosh was made under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. This plan provides for equity-based awards, such as restricted stock units, designed to compensate and incentivize directors and other eligible participants in company stock.
Was Craig Barbarosh’s Evolent Health equity transaction a market purchase or sale?
The transaction was a grant of 41,096 restricted stock units, not an open-market purchase or sale. It was awarded at a reported price of $0.0000 per share, reflecting a compensation-related equity award rather than a voluntary market trade by the director.
AI-generated analysis. How Rhea-AI works. Not financial advice.
